Int.biotech. Share News (IBT)

International Biotechnology Trust Sees Increases In NAV And Total Assets

Hydrodec CEO marks arrival, GSK associate stocks up

The new Chief Executive of Hydrodec has topped up his stake in the firm with £51,000-worth of shares, less than a month since he took up his new post. Ian Smale, whose appointment was announced in early November, bought 400,000 shares at 12.75p each. In January the company announced that its rev

International Biotechnology Trust NAV/Share 168.2P

LONDON (Dow Jones)--International Biotechnology Trust PLC (IBT.LN) said Thursday its net asset value per share at May 31 was 168.2 pence, compared with 164.1 pence at Feb. 28. MAIN FACTS: -Total Net Asset Value GBP102.7 million (Feb. 28: GBP101.1 million) -Shares at 0945 GMT flat at 139.

SV Life Sciences' Fifth Fund Raises $523M For Investments

LONDON (Dow Jones)--Venture capital firm SV Life Sciences Tuesday said it agreed to raise $523 million for its fifth fund dedicated to investing in life science companies like drug developers and medical device firms. The money raised exceeded the company's target of $400 million and SV Life Sci

International Biotechnology Buys 20,000 In Own Shares

LONDON (Dow Jones)--International Biotechnology Trust Plc (IBT.LN), announced Thursday it purchased 200,000 of its own ordinary shares of 25 pence each at 142.00 pence per share and the company intends to hold these shares in treasury. MAIN FACTS: -Shares at 1502 GMT stood at 143 pence.

Friday tips round-up: Misys, UK Mail, Intercede

Misys is in good health but the Independent says it has had a very good run from these shares and anyone who got in below 129.5p could happily take profits. However, that would miss out on a banking recovery, which will happen before too long, so hold. UK Mail has a low-cost network, growing market

Britvic directors cash in

Fizzy drinks maker Britvic's chief executive and finance director have taken up shares and sold the share options for a second day running. The latest sales are of shares acquired under the Britvic Performance Share Plan at no cost. Chief executive Paul Moody was awarded 84,694 shares and sold 34,